Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol
- PMID: 219036
- PMCID: PMC371961
- DOI: 10.1172/JCI109310
Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol
Abstract
17 beta-estradiol enchances androgen-induced prostate growth in the castrate dog to a degree comparable to that seen in spontaneous prostatic hypertrophy. To investigate the mechanism of this synergism, cytosol androgen binding was measured by a density gradient technique in prostates of control and 17 beta-estradiol-treated castrate dogs. [3H]Dihydrotestosterone was bound principally to a moiety that averaged 8.6S in size. Approximately twofold enhancement of this binding by 17 beta-estradiol was demonstrable after 1 wk of treatment with 750 microgram/wk and after 3 wk with 75 microgram/wk. Under conditions in which binding in the 8S region was demonstrable with dihydrotestosterone and testosterone no binding of 3 alpha-androstanediol or progesterone was detectable. Thus, enhancement by 17 beta-estradiol of a prostate cytosol androgen-binding protein occurs under circumstances in which 17 beta-estradiol enhances androgen-mediated prostatic growth.
Similar articles
-
Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.J Clin Invest. 1980 May;65(5):1051-9. doi: 10.1172/JCI109757. J Clin Invest. 1980. PMID: 6154062 Free PMC article.
-
Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.J Clin Invest. 1979 Oct;64(4):1003-10. doi: 10.1172/JCI109536. J Clin Invest. 1979. PMID: 90055 Free PMC article.
-
Effect of endocrine manipulations on the levels of cytosolic and nuclear receptors for androgens in dog prostate.Invest Urol. 1981 May;18(8):418-21. Invest Urol. 1981. PMID: 7228574
-
Histochemical studies of epithelial cell glycoconjugates in atrophic, metaplastic, hyperplastic, and neoplastic canine prostate.Lab Invest. 1984 Mar;50(3):294-302. Lab Invest. 1984. PMID: 6199584 Review.
-
Testosterone receptors in the prostate and other tissues.Vitam Horm. 1975;33:265-81. doi: 10.1016/s0083-6729(08)60960-7. Vitam Horm. 1975. PMID: 180675 Review. No abstract available.
Cited by
-
Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk.World J Urol. 2003 May;21(1):31-6. doi: 10.1007/s00345-002-0316-x. Epub 2003 Feb 14. World J Urol. 2003. PMID: 12756492 Review.
-
Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia.J Clin Invest. 1980 Sep;66(3):612-5. doi: 10.1172/JCI109895. J Clin Invest. 1980. PMID: 6156957 Free PMC article.
-
Prostate gland: structure, functions and regulation.Int Urol Nephrol. 1995;27(3):231-43. doi: 10.1007/BF02564756. Int Urol Nephrol. 1995. PMID: 7591584 Review.
-
Changes in amount and intracellular distribution of androgen receptor in human foreskin as a function of age.J Clin Invest. 1987 Jan;79(1):44-7. doi: 10.1172/JCI112805. J Clin Invest. 1987. PMID: 3491838 Free PMC article.
-
Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.J Clin Invest. 1980 May;65(5):1051-9. doi: 10.1172/JCI109757. J Clin Invest. 1980. PMID: 6154062 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources